Polymorphisms in thymidylate synthase and reduced folate carrier (<i>SLC19A1</i>) genes predict survival outcome in advanced non-small cell lung cancer patients treated with pemetrexed-based chemotherapy.

Li, Wen-Juan; Jiang, Hua; Fang, Xin-Jian; Ye, Hong-Ling; Liu, Ming-Huan; Liu, Yan-Wen; Chen, Qian; Zhang, Li; Zhang, Jin-Yu; Yuan, Chun-Luan; Zhang, Qiu-Yun

Polymorphisms in thymidylate synthase and reduced folate carrier (SLC19A1) genes predict survival outcome in advanced non-small cell lung cancer patients treated with pemetrexed-based chemotherapy.

Li, Wen-Juan; Jiang, Hua; Fang, Xin-Jian; Ye, Hong-Ling; Liu, Ming-Huan; Liu, Yan-Wen; Chen, Qian; Zhang, Li; Zhang, Jin-Yu; Yuan, Chun-Luan; Zhang, Qiu-Yun.

Afiliación

Li WJ; Department of Medical Oncology, The Second People's Hospital of Lianyungang (Lianyungang Hospital Affiliated to Bengbu Medical College), Jiangsu 222000, P.R. China.

Oncol Lett ; 5(4): 1165-1170, 2013 Apr.

Article en En | MEDLINE | ID: mdl-23599757

Palabras clave

SLC19A1; advanced non-small cell lung cancer; methylenetetrahydrofolate reductase; pemetrexed; single nucleotide polymorphism; thymidylate synthase

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2013 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google